TwinBeech Capital’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-110,538
Closed -$3.76M 944
2024
Q3
$3.76M Buy
+110,538
New +$3.11M 0.07% 303
2023
Q4
Sell
-98,599
Closed -$2.2M 916
2023
Q3
$2.2M Buy
98,599
+78,352
+387% +$2.01M 0.04% 397
2023
Q2
$516K Sell
20,247
-92,644
-82% -$2.25M 0.01% 507
2023
Q1
$2.52M Sell
112,891
-12,588
-10% -$304K 0.05% 347
2022
Q4
$2.98M Buy
125,479
+8,549
+7% +$199K 0.06% 358
2022
Q3
$1.94M Buy
+116,930
New +$2.63M 0.05% 343
2021
Q3
Sell
-7,470
Closed -$299K 775
2021
Q2
$299K Buy
+7,470
New +$319K 0.04% 374

Other funds holding VCYT

TwinBeech Capital's VCYT Position: Q4 2024 in Review

TwinBeech Capital sold out of Veracyte (VCYT) in Q4 2024, closing a stake of 110,538 shares — an estimated $3.76M sold.

TwinBeech Capital first reported a position in VCYT in Q2 2021 and held it in 7 quarters. The position peaked at $3.76M in Q3 2024. 318 funds tracked by Wall St. Rank hold VCYT as of Q4 2024.

  • TwinBeech Capital reported no remaining Veracyte position as of Q4 2024 after selling out during the quarter.
  • TwinBeech Capital sold 110,538 Veracyte shares in Q4 2024, an estimated $3.76M.
  • TwinBeech Capital first reported a position in Veracyte in Q2 2021 and held it in 7 quarters.
  • TwinBeech Capital's Veracyte position peaked at $3.76M in Q3 2024.
  • 318 funds tracked by Wall St. Rank held Veracyte as of Q4 2024.

Based on TwinBeech Capital's 13F filing for Q4 2024, filed 14 Feb 2025.